Polycystic Ovary syndrome: A disorder of alarming proportion

Authors

  • Irfat Ara
  • Maqsood Mohd
  • Mudasir Maqbool
  • Tawseef Ahmad Hajam

Abstract

 

Polycystic Ovary Syndrome is one of the most important endocrine disorders that affects women of the reproductive age and may cause serious complications. Insulin resistance plays a key role in the pathophysiology of this syndrome, and this makes the use of oral anti-diabetic drugs most compelling. The majority of studies have shown amelioration of typical symptoms such as hyperandrogenism and cycle irregularities following the use of oral anti-diabetics, and ovulation and pregnancy rates increased. The reproductive and metabolic features of PCOS are sometimes reversible with lifestyle modifications such as weight loss and exercise. Further research is needed to find the exact etiology, methods of prevention and proper management of this endocrine disorder. Though, a plethora of treatment options have arrived for PCOS in recent years the lifestyle modification including a structured meal plan and exercise schedule remains the cornerstone and the most effective modality of treatment till date. As a general rule all other treatment options are added to this depending upon the gravity of the presenting problems. PCOS has achieved an alarming proportion. In this review, we will briefly describe about this multifaceted disorder.

 

Keywords: Polycystic ovary syndrome, insulin resistance, Metformin, exercise, weight reduction.


Cite this Article

Irfat Ara, Maqsood Mohd, Mudasir Maqbool, Tawseef Ahmad Hajam. Polycystic Ovary syndrome: A disorder of alarming proportion. Research & Reviews: A Journal Pharmaceutical Science. 2020; 11(2): 1–7p.


Downloads

Published

2020-09-01

Issue

Vol. 11 No. 2 (2020)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.